Benzinga

Benzinga

Benzinga

lunes, agosto 31

TG Therapeutics Inc

TGTXNASDAQ
Trade with Public
Trade with Public
$53.93
-1.79-3.21%
al cierre: Aug 28, 5:00 PM EST
$53.93
N/A
After hour: Aug 28, 4:54 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

TG Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for TG Therapeutics (TGTX).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

6Buy
1Hold
1Sell
Consensus RatingBuy# Analysts8Avg. Consensus PT$51Upside to Avg. PT-4.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026JP MorganBrian ChengPT RaiseOverweight$65→$72
Jul 27, 2026B. Riley SecuritiesWilliam WoodsPT RaiseBuy$55→$86
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

JP Morgan analyst Brian Cheng maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and raises the price target from $65 to $72.
Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

B. Riley Securities analyst William Woods maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $55 to $86.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $70 to $77.
Benzinga Newsdesk

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

B of A Securities analyst Alec Stranahan maintains TG Therapeutics (NASDAQ:TGTX) with a Underperform and raises the price target from $17 to $20.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $70 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $70 price target.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved